patients
The median PFS of PP(+) (n = 89) and PP(−) (n = 143) older
advanced NSCLC patients was 9.8 months (95% CI = 7.8–14.0) and 13.8
months (95% CI = 11.5–16.3), respectively (P = 0.047)
(Figure 3A ), while the median OS was 19.4 months (95% CI =
14.1–24.8) and 27.3 months (95% CI = 22.6–36.4), respectively
(P < 0.001) (Figure 3B ).
Survival analysis in PIM-STOPP v2 (+) and PIM-STOPP v2 (–)
older advanced NSCLC patients
The median PFS of PIM-STOPP v2(+) (n = 74) and PIM-STOPP v2(−)
(n = 158) older advanced NSCLC patients was 10.1 months (95% CI
= 7.8–13.8) and 14.3 months (95% CI = 11.4–16.1), respectively
(P = 0.14) (Supplementary Figure 1A ), while the median
OS was 19.8 months (95% CI = 14.1–25.9) and 26.0 months (95% CI =
22.6–33.1), respectively (P = 0.06) (Supplementary
Figure 1B ).